RxSight (RXST) News Today $33.66 -4.53 (-11.86%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period State Street Corp Boosts Stock Holdings in RxSight, Inc. (NASDAQ:RXST)State Street Corp lifted its holdings in shares of RxSight, Inc. (NASDAQ:RXST - Free Report) by 8.3% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 817,671 shares of the company's stock after buying anDecember 21 at 3:40 AM | marketbeat.comForecasting The Future: 4 Analyst Projections For RxSightDecember 21 at 2:30 AM | benzinga.comStifel Downgrades RxSight (RXST)December 21 at 2:30 AM | msn.comDo You Believe in the Long-Term Growth Potential of RxSight (RXST)?December 21 at 2:30 AM | msn.comRxSight (NASDAQ:RXST) Hits New 52-Week Low - Time to Sell?RxSight (NASDAQ:RXST) Hits New 52-Week Low - Should You Sell?December 20 at 10:37 AM | marketbeat.comRxSight (NASDAQ:RXST) Downgraded by Stifel Nicolaus to HoldStifel Nicolaus downgraded RxSight from a "buy" rating to a "hold" rating and decreased their price target for the stock from $65.00 to $40.00 in a report on Friday.December 20 at 8:31 AM | marketbeat.comPositive week for RxSight, Inc. (NASDAQ:RXST) institutional investors who lost 1.6% over the past yearDecember 20 at 8:06 AM | finance.yahoo.comRxSight (NASDAQ:RXST) Trading Down 0.7% - Here's WhyRxSight (NASDAQ:RXST) Stock Price Down 0.7% - Here's WhyDecember 17, 2024 | marketbeat.comRxSight (NASDAQ:RXST) Trading 3.7% Higher - Here's What HappenedRxSight (NASDAQ:RXST) Trading 3.7% Higher - Still a Buy?December 16, 2024 | marketbeat.comRxSight, Inc. (NASDAQ:RXST) Shares Sold by Lord Abbett & CO. LLCLord Abbett & CO. LLC reduced its holdings in RxSight, Inc. (NASDAQ:RXST - Free Report) by 39.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,049,822 shares of the company's stock after selling 6December 15, 2024 | marketbeat.comRxSight (NASDAQ:RXST) Stock Price Up 1.3% - Should You Buy?RxSight (NASDAQ:RXST) Trading 1.3% Higher - Should You Buy?December 13, 2024 | marketbeat.comRxSight (NASDAQ:RXST) Trading Down 1.6% - Here's What HappenedRxSight (NASDAQ:RXST) Shares Down 1.6% - What's Next?December 12, 2024 | marketbeat.comWells Fargo Downgrades RxSight (RXST)December 12, 2024 | msn.comRxSight downgraded to Equal Weight from Overweight at Wells FargoDecember 11, 2024 | markets.businessinsider.comRxSight (NASDAQ:RXST) Trading Down 4.8% - Should You Sell?RxSight (NASDAQ:RXST) Shares Down 4.8% - Here's What HappenedDecember 11, 2024 | marketbeat.comRxSight (NASDAQ:RXST) Shares Gap Down - Here's WhyRxSight (NASDAQ:RXST) Shares Gap Down - What's Next?December 11, 2024 | marketbeat.comRxSight (NASDAQ:RXST) Earns "Equal Weight" Rating from Wells Fargo & CompanyWells Fargo & Company reissued an "equal weight" rating and issued a $42.00 price objective (down from $56.00) on shares of RxSight in a research note on Wednesday.December 11, 2024 | marketbeat.comRxSight (NASDAQ:RXST) Trading Down 1.9% - Here's What HappenedRxSight (NASDAQ:RXST) Shares Down 1.9% - Here's WhyDecember 10, 2024 | marketbeat.comRxSight, Inc. (NASDAQ:RXST) Shares Sold by Two Sigma Advisers LPTwo Sigma Advisers LP lowered its holdings in RxSight, Inc. (NASDAQ:RXST - Free Report) by 36.6% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 206,800 shares of the company's stock after selling 119,20December 10, 2024 | marketbeat.comRxSight (NASDAQ:RXST) Trading Down 0.1% - What's Next?RxSight (NASDAQ:RXST) Shares Down 0.1% - Here's WhyDecember 9, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Raises Stock Holdings in RxSight, Inc. (NASDAQ:RXST)Charles Schwab Investment Management Inc. boosted its position in RxSight, Inc. (NASDAQ:RXST - Free Report) by 28.1% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 285,329 shares of the company's stock after purchasing an additional 62,507 shares dDecember 9, 2024 | marketbeat.comRxSight’s Promising Growth with Light Adjustable Lens: A Buy Recommendation by Danielle AntalffyDecember 7, 2024 | markets.businessinsider.comUBS Initiates Coverage of RxSight (RXST) with Buy RecommendationDecember 7, 2024 | msn.comRxSight, Inc. (NASDAQ:RXST) Holdings Trimmed by Fmr LLCFmr LLC cut its holdings in RxSight, Inc. (NASDAQ:RXST - Free Report) by 4.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,202,251 shares of the company's stock after selling 52,078 shDecember 7, 2024 | marketbeat.comRxSight (NASDAQ:RXST) Stock Price Down 2% - Time to Sell?RxSight (NASDAQ:RXST) Stock Price Down 2% - Here's WhyDecember 6, 2024 | marketbeat.comRxSight (NASDAQ:RXST) Coverage Initiated at UBS GroupUBS Group initiated coverage on shares of RxSight in a research report on Friday. They set a "buy" rating and a $52.00 price objective on the stock.December 6, 2024 | marketbeat.comPoint72 Asset Management L.P. Acquires 384,041 Shares of RxSight, Inc. (NASDAQ:RXST)Point72 Asset Management L.P. lifted its holdings in shares of RxSight, Inc. (NASDAQ:RXST - Free Report) by 610.2% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 446,976 shares of the company's stock after purchasing an additionalDecember 6, 2024 | marketbeat.comRxSight (NASDAQ:RXST) Trading Down 0.9% - What's Next?RxSight (NASDAQ:RXST) Stock Price Down 0.9% - Time to Sell?December 5, 2024 | marketbeat.comRA Capital Management L.P. Has $193.61 Million Stake in RxSight, Inc. (NASDAQ:RXST)RA Capital Management L.P. lifted its stake in shares of RxSight, Inc. (NASDAQ:RXST - Free Report) by 6.0% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,916,825 shares of the company's stock after pDecember 5, 2024 | marketbeat.comRxSight (NASDAQ:RXST) Trading 0.3% Higher - Here's What HappenedRxSight (NASDAQ:RXST) Stock Price Up 0.3% - Time to Buy?December 4, 2024 | marketbeat.comParkman Healthcare Partners LLC Has $9.11 Million Stock Holdings in RxSight, Inc. (NASDAQ:RXST)Parkman Healthcare Partners LLC lowered its holdings in RxSight, Inc. (NASDAQ:RXST - Free Report) by 37.9% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 184,320 shares of the company's stock after selling 112,419 sDecember 4, 2024 | marketbeat.comRxSight, Inc. (NASDAQ:RXST) Insider Sells $143,078.40 in StockDecember 4, 2024 | insidertrades.comIlya Goldshleger Sells 3,105 Shares of RxSight, Inc. (NASDAQ:RXST) StockRxSight, Inc. (NASDAQ:RXST - Get Free Report) insider Ilya Goldshleger sold 3,105 shares of the stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $46.08, for a total transaction of $143,078.40. Following the completion of the sale, the insider now directly owns 42,246 shares in the company, valued at approximately $1,946,695.68. The trade was a 6.85 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website.December 3, 2024 | marketbeat.comRxSight (NASDAQ:RXST) Shares Down 2.7% - Here's WhyRxSight (NASDAQ:RXST) Trading Down 2.7% - Here's What HappenedDecember 3, 2024 | marketbeat.comBank of Montreal Can Raises Position in RxSight, Inc. (NASDAQ:RXST)Bank of Montreal Can grew its position in shares of RxSight, Inc. (NASDAQ:RXST - Free Report) by 32.4% during the third quarter, according to its most recent filing with the SEC. The firm owned 119,580 shares of the company's stock after acquiring an additional 29,230 shares during the period. BankDecember 3, 2024 | marketbeat.comRxSight (NASDAQ:RXST) Stock Price Down 1.7% - Should You Sell?RxSight (NASDAQ:RXST) Stock Price Down 1.7% - Time to Sell?December 2, 2024 | marketbeat.comPDT Partners LLC Buys Shares of 18,129 RxSight, Inc. (NASDAQ:RXST)PDT Partners LLC purchased a new position in shares of RxSight, Inc. (NASDAQ:RXST - Free Report) in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 18,129 shares of the company's stock, valued at approximately $896,000. SeveralDecember 2, 2024 | marketbeat.comWasatch Advisors LP Acquires 66,887 Shares of RxSight, Inc. (NASDAQ:RXST)Wasatch Advisors LP lifted its holdings in RxSight, Inc. (NASDAQ:RXST - Free Report) by 47.8% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 206,740 shares of the company's stock after buying an additionDecember 1, 2024 | marketbeat.comWalleye Capital LLC Grows Stock Holdings in RxSight, Inc. (NASDAQ:RXST)Walleye Capital LLC increased its stake in RxSight, Inc. (NASDAQ:RXST - Free Report) by 620.2% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 129,687 shares of the company's stock after purchasing an additional 111,681 shaDecember 1, 2024 | marketbeat.comIntech Investment Management LLC Makes New $598,000 Investment in RxSight, Inc. (NASDAQ:RXST)Intech Investment Management LLC acquired a new position in shares of RxSight, Inc. (NASDAQ:RXST - Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 12,091 shares of the company's stock, valued at approximatelyDecember 1, 2024 | marketbeat.comRxSight's Momentum In The Large Cataract Surgery Market Merits A Close EyeNovember 29, 2024 | seekingalpha.comRxSight (NASDAQ:RXST) Trading 0.9% Higher - Should You Buy?RxSight (NASDAQ:RXST) Shares Up 0.9% - Should You Buy?November 29, 2024 | marketbeat.comSummit Partners Public Asset Management LLC Decreases Stake in RxSight, Inc. (NASDAQ:RXST)Summit Partners Public Asset Management LLC reduced its position in RxSight, Inc. (NASDAQ:RXST - Free Report) by 15.5% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 687,711 shares of the company's stock after selling 126,122 shares during the period.November 29, 2024 | marketbeat.comDynamic Technology Lab Private Ltd Makes New $605,000 Investment in RxSight, Inc. (NASDAQ:RXST)Dynamic Technology Lab Private Ltd acquired a new position in shares of RxSight, Inc. (NASDAQ:RXST - Free Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 12,232 shares of the compaNovember 29, 2024 | marketbeat.comRxSight (NASDAQ:RXST) Shares Up 1.6% - Should You Buy?RxSight (NASDAQ:RXST) Trading Up 1.6% - Here's What HappenedNovember 27, 2024 | marketbeat.comRxSight, Inc. (NASDAQ:RXST) Insider Ilya Goldshleger Sells 3,100 SharesNovember 27, 2024 | insidertrades.comRxSight, Inc. (NASDAQ:RXST) Given Consensus Recommendation of "Buy" by AnalystsRxSight, Inc. (NASDAQ:RXST - Get Free Report) has been assigned a consensus rating of "Buy" from the eight analysts that are currently covering the stock, Marketbeat.com reports. Eight investment analysts have rated the stock with a buy rating. The average 1-year target price among brokerages thatNovember 27, 2024 | marketbeat.comInsider Selling: RxSight, Inc. (NASDAQ:RXST) Insider Sells 3,100 Shares of StockRxSight, Inc. (NASDAQ:RXST - Get Free Report) insider Ilya Goldshleger sold 3,100 shares of the stock in a transaction that occurred on Friday, November 22nd. The shares were sold at an average price of $45.00, for a total transaction of $139,500.00. Following the transaction, the insider now owns 42,246 shares in the company, valued at approximately $1,901,070. This trade represents a 6.84 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.November 26, 2024 | marketbeat.comRxSight, Inc. (NASDAQ:RXST) Director Sells $173,518.16 in StockRxSight, Inc. (NASDAQ:RXST - Get Free Report) Director Shweta Maniar sold 3,782 shares of the stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $45.88, for a total transaction of $173,518.16. Following the completion of the sale, the director now owns 10,902 shares in the company, valued at $500,183.76. This represents a 25.76 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.November 26, 2024 | marketbeat.comRxSight (NASDAQ:RXST) Trading Down 0.8% - Time to Sell?RxSight (NASDAQ:RXST) Shares Down 0.8% - Should You Sell?November 26, 2024 | marketbeat.com Get RxSight News Delivered to You Automatically Sign up to receive the latest news and ratings for RXST and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin RXST Media Mentions By Week RXST Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RXST News Sentiment▼0.050.60▲Average Medical News Sentiment RXST News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RXST Articles This Week▼115▲RXST Articles Average Week Get RxSight News Delivered to You Automatically Sign up to receive the latest news and ratings for RXST and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Inspire Medical Systems News PROCEPT BioRobotics News Axonics News NovoCure News Envista News Inari Medical News iRhythm Technologies News LivaNova News Enovis News Warby Parker News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RXST) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RxSight, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RxSight With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RXST Stock Alerts